Kyriazi Theo Melas - Jun 8, 2021 Form 4 Insider Report for Evelo Biosciences, Inc. (EVLO)

Role
Director
Signature
/s/ Jonathan Poole, Attorney-in-Fact for Theodose Melas-Kyriazi
Stock symbol
EVLO
Transactions as of
Jun 8, 2021
Transactions value $
$0
Form type
4
Date filed
6/11/2021, 04:07 PM
Next filing
Jun 22, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Stock Option (Right to Buy) Award $0 +15.7K $0.00 15.7K Jun 8, 2021 Common Stock 15.7K $14.60 Direct F1
transaction EVLO Stock Option (Right to Buy) Award $0 +1.81K $0.00 1.81K Jun 9, 2021 Common Stock 1.81K $14.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of June 8, 2022 and the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant.